CAPROLACTAM CHEMICALS LTD. is a Chemicals & Petrochemicals company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 2 | 10 | 7 | 7 | 11 |
| EBITDA (ex other income) | (1) | 5 | 2 | 2 | 4 |
| margin % | (27.5) | 47.5 | 31.2 | 22.6 | 42.3 |
| Owners' profit | (1) | 3 | 0 | (1) | 2 |
| EPS, as reported (₹) | (2.79) | 5.54 | 0.43 | 1.54 | 3.83 |
| ROE % · ROCE % | (45.8) · (21.5) | 47.7 · 44.1 | 3.6 · 10.6 | (14.7) · (1.1) | 26.8 · 34.7 |
| Debt / equity (x) | 1.34 | 1.06 | 1.06 | 1.80 | 1.40 |
| Cash from operations | 3 | 1 | 2 | (1) | 2 |
| Capex | 0 | 0 | 0 | (2) | (1) |
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 3 |
| Profit before tax | (0) | 0 | (0) | (0) | 0 | 0 | 1 | 1 |
| Net profit | (0) | 0 | (0) | (0) | 0 | 0 | 0 | 1 |
| EPS (₹) | (0.58) | 0.09 | (0.07) | 0.98 | 0.79 | 0.27 | 0.95 | 1.82 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| DEEPAK FERTILIZERS & PETR | 16,727 | 17.0 | 2.24 | 12.2 | 9.9 | 8.4 | 14.6 | 26.1 |
| TATA CHEMICALS LTD | 15,683 | — | 0.71 | 141.2 | (7.7) | (5.0) | 7.4 | 14.4 |
| GUJ NAR VAL FER & CHEM L | 8,273 | 8.0 | 0.91 | 6.0 | 8.9 | 10.3 | 8.7 | 22.1 |
| TANFAC INDUSTRIES LTD. | 6,773 | 55.4 | 18.15 | — | 18.8 | 24.3 | — | 16.0 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 10 Sept 2026 · Internal Auditor Resigns, New Auditor Appointed | management changes | low | — | — |
| 4 Sept 2026 · 37th AGM notice and Annual Report dispatch | compliance | minimal | — | — |
| 2 Sept 2026 · FY 2025-26 annual report shows return to profit | board shareholder meetings | medium | — | — |
| 2 Sept 2026 · Notice of 37th AGM on 28 September 2026 | board shareholder meetings | low | — | — |
| 31 Aug 2026 · Board recommends new Statutory Auditor, fixes AGM date Sept 28 | management changes | medium | — | — |
| 17 Aug 2026 · Caprolactam Chemicals Q1 FY27 results published in newspapers; revenue drops, swings to loss | compliance | minimal | — | — |
| 13 Aug 2026 · Q1 FY27 results: Revenue plunges about 82%, swings to loss | results | high | — | — |
| 30 Jul 2026 · Board meeting on Aug 13, 2026 to approve Q1 FY26 results | results | low | — | — |
| 2 Jul 2026 · Compliance Certificate under Reg 74(5) for Q1 FY27 | compliance | minimal | — | — |
| 25 Jun 2026 · Trading Window Closure Ahead of Q1 FY27 Results | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| GUJARAT ALKALIES & CHEM |
| 5,179 |
| 78.0 |
| 1.00 |
| 10.7 |
| (0.0) |
| 0.7 |
| 12.4 |
| 18.4 |
| GHCL LIMITED | 3,879 | 8.4 | 1.09 | 5.1 | 13.3 | 16.6 | 1.1 | 23.9 |
| GRAUER & WEIL IND LTD | 3,469 | 21.2 | 3.21 | 14.1 | 15.2 | 19.2 | 14.5 | 20.4 |
| J.G.CHEMICALS LIMITED | 2,330 | 31.0 | 4.31 | 23.7 | 12.7 | 16.9 | — | 11.5 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 12.8 | 17.0 | 21 of 57 | 64% |
| P/B | 3.4 | 1.4 | 45 of 59 | 24% |
| ROCE | 26.1 | 6.2 | 5 of 65 | 94% |
| ROE | 26.8 | 4.9 | 3 of 65 | 97% |
| Debt / Equity | 1.4 | 0.2 | 58 of 65 | 11% |
| EBITDA margin | 54.1 | 13.3 | 4 of 58 | 95% |
| Revenue growth | 90.7 | 6.7 | 2 of 54 | 98% |
| Profit growth | 285.8 | 21.0 | 9 of 64 | 87% |
| Market cap | 23 | 77 | 48 of 65 | 27% |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
